Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline Dren Bio deep B-cell depleter program has the potential to reset the immune ...

Rese-cel is the lead clinical candidate in development by Cabaletta Bio, a biotechnology company focused on developing and launching the first curative targeted cell therapies designed ...

Cell programming biotech bit.bio is slimming its workforce by 25% as the company pivots to focus on biomedical tools instead of therapeutics development. The decision was driven by “shifting ...

Dren Bio deep B-cell depleter program has the potential to reset the immune system Acquisition underpins path for Sanofi becoming leading immunology company Sanofi to pay $600 million up front Paris, ...

Here are 30+ of her most inspiring quotes to help students stay focused and determined. She once held the record for the most spacewalks by a woman (seven) and the longest total time spent on ...

The TC20 automated cell counter counts mammalian cells in one simple step using its innovative auto-focus technology and sophisticated cell counting algorithm to produce accurate cell counts in ...

Dren Bio’s CEO and co-founder Nenad Tomasevic said in this morning’s release that, as “a leader in immunology,” Sanofi was “ideally positioned to unlock the power of deep B-cell ...

Kerr was renowned for his inspirational contribution to education, cell death and giving a generation of medical students a solid understanding of the pathological basis of disease. The full ...

Apr. 11, 2025 — A new, error-corrected method for detecting cancer from blood samples is much more sensitive and accurate than prior methods and may be useful for monitoring disease status in ...

Get Instant Summarized Text (Gist) Offering "streak incentives" can enhance employee productivity more effectively than single payouts. Employees complete more tasks when rewarded for consecutive ...

Explore Cabaletta Bio stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CABA. US Stocks Likely To Open In The Green To End November On A High: Are Markets ...